Dynavax Capital Stock from 2010 to 2025

DVAX Stock

USD 13.84 0.02 0.14%

Dynavax Technologies Capital Stock yearly trend continues to be fairly stable with very little volatility. Capital Stock will likely drop to about 119.9 K in 2025. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

125 K

Current Value

119.9 K

Quarterly Volatility

29.5 K

Credit Downgrade

Yuan Drop

Covid

Check Dynavax Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dynavax Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.5 M, Interest Expense of 4.2 M or Other Operating Expenses of 295.4 M, as well as many indicators such as Price To Sales Ratio of 5.69, Dividend Yield of 0.0 or PTB Ratio of 4.39. Dynavax financial statements analysis is a perfect complement when working with Dynavax Technologies Valuation or Volatility modules.

Check out the analysis of Dynavax Technologies Correlation against competitors.

For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Latest Dynavax Technologies' Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Dynavax Technologies over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Dynavax Technologies' Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dynavax Technologies' overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Dynavax Capital Stock Regression Statistics

	Arithmetic Mean	86,681
	Geometric Mean	82,302
	Coefficient Of Variation	34.06
	Mean Deviation	26,977
	Median	63,000
	Standard Deviation	29,521
	Sample Variance	871.5M
	Range	67K
	R-Value	0.88
	Mean Square Error	215M
	R-Squared	0.77
	Slope	5,440
	Total Sum of Squares	13.1B

Dynavax Capital Stock History

	2025	119.9 K
	2024	125 K
	2023	130 K
	2022	128 K
	2021	123 K
	2020	110 K
	2019	84 K

Other Fundumenentals of Dynavax Technologies

Issuance Of Capital Stock

Dynavax Technologies Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Accounts Payable	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Total Current Assets	Net Receivables	Good Will	Intangible Assets	Long Term Debt	Short Term Debt	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.87	-0.48	0.87	0.49	0.83	0.22	0.9	0.6	0.26	0.97	0.82	-0.62	-0.11	0.88	-0.3	0.85	0.8	0.78	0.83	-0.53	0.89	0.88	0.95
Total Stockholder Equity	0.87		-0.22	0.52	0.49	0.96	0.24	0.63	0.2	0.34	0.94	0.59	-0.59	-0.17	0.66	-0.16	0.98	0.64	0.55	0.64	-0.61	0.92	0.89	0.78
Retained Earnings	-0.48	-0.22		-0.62	-0.55	-0.25	0.01	-0.74	-0.4	-0.35	-0.4	-0.41	0.46	-0.09	-0.68	0.7	-0.12	-0.81	-0.73	-0.78	0.08	-0.27	-0.26	-0.55
Total Liab	0.87	0.52	-0.62		0.37	0.47	0.14	0.95	0.84	0.11	0.76	0.84	-0.48	-0.02	0.88	-0.37	0.49	0.76	0.81	0.81	-0.31	0.64	0.64	0.87
Accounts Payable	0.49	0.49	-0.55	0.37		0.64	-0.04	0.57	-0.05	0.7	0.57	0.09	-0.7	0.09	0.62	-0.35	0.48	0.61	0.68	0.64	-0.67	0.39	0.42	0.46
Short Term Investments	0.83	0.96	-0.25	0.47	0.64		0.22	0.61	0.08	0.54	0.93	0.43	-0.6	-0.11	0.7	-0.15	0.96	0.65	0.63	0.65	-0.71	0.87	0.87	0.77
Common Stock	0.22	0.24	0.01	0.14	-0.04	0.22		0.11	0.16	0.02	0.22	0.2	0.44	-0.17	0.12	0.51	0.21	0.07	0.08	0.0	0.01	0.21	0.21	0.2
Property Plant Equipment	0.9	0.63	-0.74	0.95	0.57	0.61	0.11		0.72	0.25	0.83	0.77	-0.64	-0.1	0.91	-0.48	0.59	0.86	0.85	0.91	-0.44	0.68	0.69	0.9
Current Deferred Revenue	0.6	0.2	-0.4	0.84	-0.05	0.08	0.16	0.72		-0.41	0.44	0.73	-0.16	-0.11	0.49	-0.23	0.18	0.44	0.4	0.48	-0.01	0.33	0.36	0.55
Net Debt	0.26	0.34	-0.35	0.11	0.7	0.54	0.02	0.25	-0.41		0.36	-0.07	-0.36	0.11	0.54	-0.13	0.35	0.44	0.6	0.45	-0.46	0.34	0.33	0.42
Total Current Assets	0.97	0.94	-0.4	0.76	0.57	0.93	0.22	0.83	0.44	0.36		0.69	-0.64	-0.11	0.84	-0.25	0.93	0.76	0.75	0.79	-0.63	0.92	0.92	0.91
Net Receivables	0.82	0.59	-0.41	0.84	0.09	0.43	0.2	0.77	0.73	-0.07	0.69		-0.41	-0.12	0.71	-0.25	0.56	0.63	0.6	0.68	-0.15	0.7	0.6	0.79
Good Will	-0.62	-0.59	0.46	-0.48	-0.7	-0.6	0.44	-0.64	-0.16	-0.36	-0.64	-0.41		-0.03	-0.61	0.54	-0.58	-0.59	-0.59	-0.7	0.59	-0.54	-0.51	-0.56
Intangible Assets	-0.11	-0.17	-0.09	-0.02	0.09	-0.11	-0.17	-0.1	-0.11	0.11	-0.11	-0.12	-0.03		0.06	-0.09	-0.17	0.01	0.28	-0.06	0.0	-0.15	-0.15	-0.16
Long Term Debt	0.88	0.66	-0.68	0.88	0.62	0.7	0.12	0.91	0.49	0.54	0.84	0.71	-0.61	0.06		-0.4	0.63	0.86	0.97	0.9	-0.46	0.76	0.74	0.94
Short Term Debt	-0.3	-0.16	0.7	-0.37	-0.35	-0.15	0.51	-0.48	-0.23	-0.13	-0.25	-0.25	0.54	-0.09	-0.4		-0.1	-0.61	-0.42	-0.57	0.06	-0.18	-0.17	-0.32
Net Tangible Assets	0.85	0.98	-0.12	0.49	0.48	0.96	0.21	0.59	0.18	0.35	0.93	0.56	-0.58	-0.17	0.63	-0.1		0.58	0.53	0.59	-0.68	0.9	0.88	0.75
Capital Surpluse	0.8	0.64	-0.81	0.76	0.61	0.65	0.07	0.86	0.44	0.44	0.76	0.63	-0.59	0.01	0.86	-0.61	0.58		0.84	0.97	-0.26	0.74	0.74	0.84
Deferred Long Term Liab	0.78	0.55	-0.73	0.81	0.68	0.63	0.08	0.85	0.4	0.6	0.75	0.6	-0.59	0.28	0.97	-0.42	0.53	0.84		0.86	-0.45	0.64	0.62	0.84
Long Term Debt Total	0.83	0.64	-0.78	0.81	0.64	0.65	0.0	0.91	0.48	0.45	0.79	0.68	-0.7	-0.06	0.9	-0.57	0.59	0.97	0.86		-0.32	0.75	0.74	0.88
Short Long Term Debt	-0.53	-0.61	0.08	-0.31	-0.67	-0.71	0.01	-0.44	-0.01	-0.46	-0.63	-0.15	0.59	0.0	-0.46	0.06	-0.68	-0.26	-0.45	-0.32		-0.38	-0.41	-0.43
Net Invested Capital	0.89	0.92	-0.27	0.64	0.39	0.87	0.21	0.68	0.33	0.34	0.92	0.7	-0.54	-0.15	0.76	-0.18	0.9	0.74	0.64	0.75	-0.38		0.98	0.87
Net Working Capital	0.88	0.89	-0.26	0.64	0.42	0.87	0.21	0.69	0.36	0.33	0.92	0.6	-0.51	-0.15	0.74	-0.17	0.88	0.74	0.62	0.74	-0.41	0.98		0.85
Capital Stock	0.95	0.78	-0.55	0.87	0.46	0.77	0.2	0.9	0.55	0.42	0.91	0.79	-0.56	-0.16	0.94	-0.32	0.75	0.84	0.84	0.88	-0.43	0.87	0.85

Click cells to compare fundamentals

About Dynavax Technologies Financial Statements

Dynavax Technologies investors use historical fundamental indicators, such as Dynavax Technologies' Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dynavax Technologies. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Capital Stock	125 K	119.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Dynavax Capital Stock from 2010 to 2025

Latest Dynavax Technologies' Capital Stock Growth Pattern

Dynavax Capital Stock Regression Statistics

Dynavax Capital Stock History

Other Fundumenentals of Dynavax Technologies

Dynavax Technologies Capital Stock component correlations

About Dynavax Technologies Financial Statements

Also Currently Popular

Additional Tools for Dynavax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY